课题基金 / 基金详情

项目摘要

项目成果

Alun Gareth Jones的其他基金

相似基金

相关文献

中文摘要
翻译
这项建议中描述的研究是基于99mTc的前提下的计划的继续 在常规临床核医学实践中仍将是重要的放射性核素。主要的推动力是 两个领域的新试剂的开发,加上一些精心挑选的化学研究 意在增加产品复合体的设计灵活性,从而增加其生物行为。第一 主要目标是继续评估能够检测到是否存在 活体恶性黑色素瘤。在当前的周期中,已经确定了几个潜在的候选者 在黑色素瘤动物模型中显示出显著的摄取,包括一种转移到肺部的黑色素瘤。一个 新的高分辨率微型SPECT相机现在可以进行纵向研究,允许监测 这是一项非常有用的能力,将在拟议期间进一步研究。这个 第二个主要目标是继续设计与5HT1A受体有亲和力的复合体。超过了 在过去的几年里,越来越清楚的是,除了他们在中央的既定职能外, 神经系统,神经递质系统在癌症的生长和扩散中起着重要作用 遍及整个人体。因此,它计划在正常大脑和体内模型中检测摄取 前列腺癌,表达这种受体类型的肿瘤的一个例子。寻找高含量的络合物 5HT1a受体的亲和力和选择性增加,具有重要的双重前景 研究的目的。第三个主要目的是检查化学行为和配基的偏好 AIMS 1和2中使用的两个金属核作为TC/Re(V)OxO核的替代品:研究相对较好的 TC(L)三羰基核和较少开发的TC(L)亚硝基核。这一化学实验将在 支持目标1和目标2的工作,因为后两个核心应在设计方面提供更大的灵活性 用于安装特定生物活性部分的最终平台。恶性黑色素瘤和前列腺癌 这两个严重的公共卫生问题在这个国家。这项工作的目的是开发一种检测 这些肿瘤在临床上使用非侵入性成像技术。MicroSPECT成像功能 小动物模型在临床前研究中也可能被证明是有用的,评估新的 这些疾病的治疗方法。
英文摘要
The research described in this proposal is the continuation of a program based on the premise that 99mTc will remain an important radionuclide in the practice of routine clinical nuclear medicine. The primary thrust is the development of new agents in two areas, coupled with some carefully selected chemical studies intended to add flexibility in the design of the product complexes and, thus, their biologic behavior. The first major aim is to continue the evaluation of technetium complexes capable of detecting the presence of malignant melanoma in vivo. Over this current cycle, several potential candidates have been identified as showing significant uptake in animal models of melanoma, including one of metastatic spread to the lungs. A new high resolution microSPECT camera has now made possible longitudinal studies that allow monitoring of tumor growth with time, a highly useful capability that will be pursued further in the proposed period. The second major aim is to continue designing complexes that have affinity for the 5HT1A receptor. Over the past few years it has become increasingly clear that, apart from their established function in the central nervous system, neurotransmitter systems play a significant role in the growth and spread of cancer throughout the human body. Thus, it is planned to assay uptake in both normal brain and in vivo models of prostate cancer, an example of tumors that express this receptor type. The search for complexes with high affinity and selectivity for 5HT1A receptors increases in importance with the prospect of important dual purposes for the research. The third major aim is to examine the chemical behavior and ligand preferences of two metal cores as alternatives to the Tc/Re(V) oxo core used in aims 1and 2: the relatively well-studied Tc(l) tricarbonyl core and the less well-explored Tc(l) nitrosyl core. This chemistry will be conducted in support of the work in aims 1 and 2 in that the latter cores should provide more flexibility in the design of the final platform for mounting a given biologically active moiety. Malignant melanoma and prostate cancer are both serious public health problems in this country. This work is designed to develop a means of detecting these tumors in the clinic using noninvasive imaging techniques. The microSPECT imaging capability with small-animal models could also prove useful in preclinical studies assessing the development of new therapies for these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
  • 批准号:
    2088804
  • 项目类别:
  • 资助金额:
    $53.07万
  • 财政年份:
    1977
  • 负责人:
    Alun Gareth Jones
  • 依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
  • 批准号:
    2633759
  • 项目类别:
  • 资助金额:
    $53.67万
  • 财政年份:
    1977
  • 负责人:
    Alun Gareth Jones
  • 依托单位:
THE CHEMISTRY OF TECHNETIUM RELATED TO NUCLEAR MEDICINE
  • 批准号:
    3172756
  • 项目类别:
  • 资助金额:
    $37.6万
  • 财政年份:
    1977
  • 负责人:
    Alun Gareth Jones
  • 依托单位:
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
  • 批准号:
    6512439
  • 项目类别:
  • 资助金额:
    $49.34万
  • 财政年份:
    1977
  • 负责人:
    Alun Gareth Jones
  • 依托单位:
海外基金